Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs HIAHX overlap: 65% of top holdings shared

Bottom line

How much do PRHSX and HIAHX overlap?

65% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 51.3% of PRHSX's assets and 54.8% of HIAHX's. They share a meaningful core but differ in the rest of the portfolio.

PRHSX holds far more positions (279 vs 79), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PRHSXHIAHX
Weight overlap (top 25)65%
Shared holdings14
Weight in shared holdings51.3%54.8%
Total positions27979
Expense ratio0.83%0.94%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings PRHSX and HIAHX have in common

Holding% of PRHSX% of HIAHXOverlap
Eli Lilly & Co14.28%12.47%12.47%
Johnson & Johnson6.63%6.63%6.63%
Unitedhealth Group Inc5.99%4.72%4.72%
Abbvie Inc5.10%3.43%3.43%
Merck & Co. Inc.4.01%6.60%4.01%
Thermo Fisher Scientific Inc2.52%1.64%1.64%
Vertex Pharmaceuticals Inc2.28%2.69%2.28%
Abbott Laboratories1.89%2.10%1.89%
Intuitive Surgical Inc1.87%2.99%1.87%
Stryker Corp1.78%1.17%1.17%
Elevance Health Inc1.53%2.96%1.53%
Danaher Corp1.43%2.65%1.43%
Cardinal Health Inc1.03%1.81%1.03%
Cvs Health Corp0.94%2.93%0.94%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Gilead Sciences Inc — 2.82%
  2. Bristol-myers Squibb Co — 2.11%
  3. Amgen Inc — 1.82%
  4. Natera Inc — 1.44%
  5. Guardant Health Inc — 1.23%
  6. Royalty Pharma Plc- Cl A — 0.97%
  7. Tenet Healthcare Corp — 0.94%
  8. Kymera Therapeutics Inc — 0.89%
  9. Protagonist Therapeutics Inc — 0.85%
  10. Moderna Therapeutics Inc — 0.83%
  11. Brightspring Health Services — 0.82%

Only in HIAHX

  1. Edwards Lifesciences Corp — 2.42%
  2. Cencora Inc — 2.07%
  3. HCA Healthcare Inc — 1.60%
  4. Regeneron Pharmaceuticals Inc — 1.52%
  5. Biogen Inc — 1.41%
  6. Agilent Technologies Inc — 1.36%
  7. Gsk Plc — 1.21%
  8. Boston Scientific Corp — 1.19%
  9. Centene Corp — 1.16%
  10. Medtronic PLC — 1.02%
  11. United Therapeutics Corp — 0.96%

Asset mix

Asset typePRHSXHIAHX
Stocks96.4%96.8%
Preferred stock3.0%—
Cash & short-term funds0.7%0.4%
Repurchase agreements—0.7%
Bonds0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryPRHSXHIAHX
US92.6%87.9%
IE0.8%2.3%
GB1.7%2.3%
NL1.0%1.8%
BE—0.8%
DK0.7%0.8%
BM0.7%—
CN—0.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PRHSX and HIAHX overlap?
About 65% by weight. 14 securities appear in both funds' top 25 holdings; they make up 51.3% of PRHSX's assets and 54.8% of HIAHX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and HIAHX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Unitedhealth Group Inc, Merck & Co. Inc., Abbvie Inc.
Should I own both PRHSX and HIAHX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or HIAHX?
PRHSX is broader, with 279 positions versus 79 for HIAHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.